Skip to main content

Matthew R Selmon, MD

Interventional Cardiology

Provider Rating

4.8

★★★★★
★★★★★

1144 reviews

Visit Preparation: 4.8
★★★★★
★★★★★
Patient Recomm...: 4.8
★★★★★
★★★★★
Provider Explan...: 3.9
★★★★★
★★★★★
Office Wait Time: 4.7
★★★★★
★★★★★

About Matthew R Selmon

Dr. Matthew Selmon is a native Texan who spent 22 years in the San Francisco Bay area as a practicing cardiologist, clinical researcher, and cofounder of Lumend, maker of the Frontrunner and Outback total occlusion devices now sold by J&J Cordis. Dr. Selmon earned his medical degree at Southwestern Medical School in Dallas, Texas. He went on to complete a cardiology fellowship at University of Missouri in Columbia, Missouri. He then completed a second fellowship in Interventional Cardiology at Sequoia Hospital in Redwood City, California. He is Board Certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. While practicing cardiology in California, Dr. Selmon partnered with world renowned cardiologist, Dr. John Simpson, on the coronary and peripheral device development company, Lumend, where he also worked as Chief Medical Officer. After Lumend was acquired in 2005 by J&J Cordis, Dr. Selmon returned to Texas to practice cardiology at Austin Heart, specializing in Interventional Cardiology, Peripheral Vascular Intervention, and Venous Disease with a special interest in chronic total occlusions (CTOs). He established Austin Heart’s new Vein Center in 2010 and currently serves as the Medical Director as he continues his work in coronary and peripheral vascular intervention. Dr. Selmon served as the national Principal Investigator for the CONNECT II Ocelot Trial, a new OCT directed peripheral chronic total occlusion device, and recently presented the findings at the VIVA Late Breaking Clinical Trials session.

Awards and Special Recognition:

Best Austin Doctors 2014 - http://www.austinmonthly.com/AM/September-2014/Best-Austin-Doctors-2014/index.php/specialty/Cardiovascular%2BDisease/

Speciality:

Interventional Cardiology, Vein Disease

Office Locations:

Heart Hospital, La Grange

News Coverage:

Avinger Enrolls First European PAD Patient in CONNECT II Global Clinical Trial
Co-principal investigators for the trial include Arne Schwindt, MD of St. Franziskus Hospital in Muenster, Germany, and Matthew Selmon, MD, Austin Heart; 

Education

Residency
University of Missouri-Columbia School of Medicine, Columbia, MO

Fellowship
University of Missouri-Columbia School of Medicine, Columbia, MO

Certifications & Memberships

Cardiovascular Disease, Interventional Cardiology

Gender

Male

Languages Spoken

English

Specialty

Interventional Cardiology

Sub Specialties

Peripheral Vascular Interventions
Venous Disorders

Office Locations

Austin Heart
3801 N. Lamar, Suite 300
Austin, TX 78756
Phone: (512) 206-3600
Fax: (512) 206-3604

Office Hours

8:00am - 5:00pm

Billing

(512) 206-4300

Additional Locations

La Grange - Austin Heart

2 St. Marks Place, Ste. 160
La Grange, TX 78945
Phone: 979-242-5677
Fax: 979-242-5680

Matthew R Selmon Media